developed a polymer prodrug nanomedicine system (Fu-PVU73) based on the cross-linking of ursodeoxycholic acid (UDCA) and vanillin (VA) via oxalic acid bonds, which breaks down and synergistically releases drugs in a high HO environment
A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma
S05E113 Beyond the Basics: Should Athletes Consider Peptide BPC 157
Choosing the right approach depends on your primary goal and your comfort level with different administration methods
Research Note: Published preclinical research, including a 2025 literature and patent review in the journal Pharmaceuticals (Jzwiak et al., 2025, Pharmaceuticals ), has documented BPC-157's effects on angiogenesis, nitric oxide signaling, and tissue protection in animal models, though authors note that no completed human clinical trials have been published to confirm these effects in people
In vitro research can show how a compound is examined under controlled laboratory model conditions